What is the current kras antibody market size?

The kras antibody market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the kras antibody market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the kras antibody market?

Key drivers include rising cancer incidence and advancements in kras antibody research and development.

What are the major challenges facing the kras antibody market?

Challenges include high development costs and stringent regulatory requirements.

Which regions are leading the kras antibody market?

North America and Europe are regional leaders, driven by strong healthcare infrastructure.

Who are the top companies in the kras antibody market?

Top companies include major pharmaceutical and biotechnology firms, such as Merck and Amgen.

What are the future opportunities in the kras antibody market?

Future opportunities include emerging applications in cancer therapy and diagnostics.

How is technology impacting the kras antibody market?

Advances in technology are improving kras antibody production and purification, enabling more effective treatments.

What is the current regulatory landscape for the kras antibody market?

The regulatory landscape is complex, with strict guidelines from agencies such as the FDA and EMA.

What is the future outlook for the kras antibody market?

The future outlook is positive, with increasing demand and ongoing research driving market growth.

kras antibody - Strategic Insights: Analysis 2025 and Forecasts 2033

kras antibody by Application (Flow Cytometry, ELISA, Western Blot, Immunoprecipitation, Immunofluorescence, Others), by Types (Monoclonal Antibody, Polyclonal Antibody), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

kras antibody Market Overview

The kras antibody market refers to the global market for antibodies targeting the KRAS protein, which is a key player in various cellular signaling pathways. As the kras antibody market size is expected to witness significant growth, driven by increasing demand for targeted therapies, the growth outlook and market forecast are crucial for stakeholders to understand the industry expansion. The scope of this market encompasses various types of kras antibodies, including monoclonal and polyclonal antibodies, and their applications in cancer research, diagnostics, and therapeutics. The current kras antibody market size is approximately $1.3 billion, with a projected growth rate of 10.5% CAGR from 2026 to 2033.

Loading chart…

The kras antibody market is driven by several key forces, including technology shifts towards more targeted and personalized therapies, regulatory support for innovative treatments, and increasing consumer awareness about the importance of early cancer diagnosis. The largest region in the kras antibody market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing investment in healthcare infrastructure and research initiatives. As the market continues to evolve, stakeholders must stay informed about the latest developments and trends to capitalize on emerging opportunities and stay ahead of the competition.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abcam plc; Thermo Fisher Scientific Inc.; Cell Signaling Technology, Inc.; Santa Cruz Biotechnology, Inc.; BD Biosciences (Becton, Dickinson and Company); Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Merck KGaA (Sigma-Aldrich); QIAGEN N.V.; Genentech (Roche)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The kras antibody market is experiencing significant growth, driven by various factors. The market dynamics are shaped by several key elements that influence the kras antibody market size and growth forecast.

Growth Drivers2 items

Increasing demand for targeted therapies, particularly in the field of oncology, is driving the adoption of kras antibody market products, with a focus on precision medicine and personalized treatment approaches.

Advances in technology, such as next-generation sequencing and gene editing, are expanding the applications of kras antibodies, enabling researchers to better understand the role of kras mutations in various diseases.

Restraints2 items

High development costs and regulatory hurdles are limiting the entry of new players in the kras antibody market, making it challenging for smaller companies to compete with established firms.

The complexity of kras biology and the limited understanding of its role in various diseases are hindering the development of effective kras antibody-based treatments, slowing down the growth forecast of the market.

Opportunities2 items

The growing awareness of the importance of early diagnosis and prevention in disease management is creating opportunities for kras antibody market players to develop innovative diagnostic and preventive solutions.

The increasing focus on immunotherapy and combination therapies is opening up new avenues for kras antibody-based treatments, enabling companies to explore novel applications and expand their product portfolios.

Challenges2 items

The kras antibody market is facing challenges related to intellectual property protection, with companies needing to navigate complex patent landscapes to develop and commercialize their products.

The reimbursement landscape for kras antibody-based treatments is evolving, with payers increasingly focusing on value-based care and cost-effectiveness, requiring companies to demonstrate the clinical and economic benefits of their products.

Market Segmentation

Loading chart…

The kras antibody market can be segmented based on Application, which includes research and diagnostic applications. The research applications account for a significant share of the kras antibody market size, driven by the increasing demand for kras antibodies in cancer research. The diagnostic applications are also expected to grow, driven by the increasing adoption of kras antibodies in biomarker testing. Understanding the kras antibody segmentation is crucial to estimate the market size and growth prospects.

The kras antibody market can also be segmented based on Types, which includes monoclonal and polyclonal antibodies. Monoclonal antibodies account for a significant share of the market, driven by their high specificity and sensitivity. Polyclonal antibodies are also widely used, driven by their ability to detect multiple epitopes. The market taxonomy of kras antibodies is complex, and understanding the different types of antibodies is essential to estimate the market size and growth prospects.

kras antibody Segmentation Breakdown10 items

Application

Flow Cytometry

ELISA

Western Blot

Immunoprecipitation

Immunofluorescence

Others

Types

Monoclonal Antibody

Polyclonal Antibody

Regional Insights

Loading chart…

The kras antibody market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share, driven by factors such as high adoption rates, favorable policies, and significant investments in research and development. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing demographics, improving infrastructure, and growing ecosystem maturity.

Key drivers for each region include: for North America, high adoption rates, favorable policies, and significant investments; for Europe, growing demographics, improving infrastructure, and increasing ecosystem maturity; for Asia Pacific, large demographics, rapid infrastructure development, and escalating ecosystem maturity; for Latin America, increasing adoption, improving policies, and growing investments; and for Middle East & Africa, rising demographics, developing infrastructure, and emerging ecosystem maturity.

The regional forecast suggests that the kras antibody market will experience significant growth in the coming years, driven by increasing demand for kras antibodies in various applications. The market growth will be influenced by factors such as adoption rates, policies, investments, demographics, infrastructure, and ecosystem maturity, which will vary across regions.

Competitive Landscape

The kras antibody market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, and regulatory approvals. The kras antibody competitive landscape is characterized by high competition, with companies employing various strategies to differentiate themselves. Key competitive levers include pricing, distribution networks, and product innovation, with companies seeking to establish strong relationships with research institutions and pharmaceutical companies.

Companies in the kras antibody market are adopting strategies such as M&A, partnerships, and product launches to expand their offerings and strengthen their market positions. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode their competitive advantages. To differentiate themselves, companies are focusing on technology, service models, and channel strength, as well as customization and cost advantages. The following companies are notable players in the market:

Abcam plc: regional expansion

Thermo Fisher Scientific Inc.: innovation pipeline

Cell Signaling Technology, Inc.: premium pricing

Santa Cruz Biotechnology, Inc.: OEM tie-ups

BD Biosciences: local manufacturing

Bio-Rad Laboratories, Inc.: vertical integration

Key kras antibody Companies10 items

Abcam plc

Thermo Fisher Scientific Inc.

Cell Signaling Technology, Inc.

Santa Cruz Biotechnology, Inc.

BD Biosciences (Becton, Dickinson and Company)

Bio-Rad Laboratories, Inc.

Agilent Technologies, Inc.

Merck KGaA (Sigma-Aldrich)

QIAGEN N.V.

Genentech (Roche)

Market Ecosystem

The kras antibody ecosystem spans multiple segments, from upstream technology providers and suppliers to midstream integrators and downstream channels, ultimately serving end users. This complex network creates and captures value through the development, manufacturing, and distribution of kras antibodies. Understanding the kras antibody ecosystem is crucial for conducting a thorough value chain analysis.

Raw material/component suppliers — provide essential materials

Technology providers — develop and license kras antibody technologies

OEMs / manufacturers — produce kras antibodies

Distributors / channel partners — deliver products to end users

Service providers / after-sales — offer support and maintenance services

End users / buyers — purchase and utilize kras antibodies

Regulators/standards bodies — establish guidelines and approvals

In the kras antibody ecosystem, control points are primarily influenced by regulators and end users, as they drive adoption and demand. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals. Switching costs and partnerships can also impact the ecosystem, particularly in regions with diverse regulatory requirements. As the kras antibody ecosystem differs by region, understanding these nuances is essential for navigating the complex web of interactions and relationships that shape the market.

Recent Industry Insights

The kras antibody industry trends have witnessed significant developments over the last 12-18 months, with a focus on advancing research and treatment options. Recent partnerships have enabled the sharing of expertise and resources, leading to improved product development. Notable mergers and acquisitions have also taken place, resulting in the expansion of product portfolios and increased market presence. Furthermore, several product and technology launches have been announced, offering enhanced diagnostic and therapeutic capabilities.

Additionally, regulatory changes have paved the way for the approval of new treatments, while shifts in consumer and enterprise trends have driven demand for more targeted and effective therapies. Funding rounds and expansions have also been secured by key players, allowing for continued investment in research and development. As the kras antibody industry continues to evolve, these recent developments are expected to have a lasting impact on the market, driving growth and innovation in the years to come.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the kras antibody market outlook. The market attractiveness is moderate, driven by increasing demand for targeted therapies in cancer treatment. The competitive intensity is high, with several key players investing in research and development. The long-term outlook is promising, with potential applications in various types of cancer. The innovation landscape is rapidly evolving, with advancements in antibody engineering and conjugation technologies.

The demand-supply balance is expected to be stable, with manufacturers ramping up production to meet growing demand. However, key risk factors include regulatory hurdles, patent expirations, and intense competition. Overall, the kras antibody market is poised for growth, driven by its potential to address unmet medical needs in cancer treatment. Decision-makers should monitor the market closely to capitalize on emerging opportunities and navigate potential challenges.

12 items

1. Executive Summary

2. kras antibody Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global kras antibody Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global kras antibody Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global kras antibody Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global kras antibody Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global kras antibody Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global kras antibody Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global kras antibody Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global kras antibody Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global kras antibody Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global kras antibody Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global kras antibody Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global kras antibody Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global kras antibody Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global kras antibody Market Competition by Key Manufacturers

9.1. Global kras antibody Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global kras antibody: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abcam plc

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Thermo Fisher Scientific Inc.

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Cell Signaling Technology, Inc.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Santa Cruz Biotechnology, Inc.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. BD Biosciences (Becton, Dickinson and Company)

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Bio-Rad Laboratories, Inc.

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Agilent Technologies, Inc.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Merck KGaA (Sigma-Aldrich)

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. QIAGEN N.V.

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Genentech (Roche)

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global kras antibody Market

Figure 4: Global kras antibody Market: Drivers

Figure 5: Global kras antibody Market: Challenges

Figure 6: Global kras antibody Market: Trends

Figure 7: Global kras antibody Market: Opportunity

Figure 8: Global kras antibody Market: Restraint

Figure 9: Global kras antibody Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global kras antibody Market Value (USD Million) By Region

Figure 19: Global kras antibody Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global kras antibody Market Value (USD Million) By Region

Figure 27: Global kras antibody Market Share (%) By: Regions (2032)

Figure 28: Global kras antibody Market Volume (K) By Region

Figure 29: Global kras antibody Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global kras antibody Market Value (USD Million) By Region

Figure 37: Global kras antibody Market Share (%) By: Regions (2032)

Figure 38: Global kras antibody Market Volume (K) By Region

Figure 39: Global kras antibody Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global kras antibody Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global kras antibody Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global kras antibody Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global kras antibody Market Value (USD Million) By Region

Table 14: Global kras antibody Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global kras antibody Market Volume (K) By Region

Table 31: Global kras antibody Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global kras antibody Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global kras antibody Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global kras antibody Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abcam plc Basic Information And Sales Area

Table 52: Abcam plc. Products Portfolio

Table 53: Thermo Fisher Scientific Inc. Basic Information And Sales Area

Table 54: Thermo Fisher Scientific Inc.. Products Portfolio

Table 55: Cell Signaling Technology, Inc. Basic Information And Sales Area

Table 56: Cell Signaling Technology, Inc.. Products Portfolio

Table 57: Santa Cruz Biotechnology, Inc. Basic Information And Sales Area

Table 58: Santa Cruz Biotechnology, Inc.. Products Portfolio

Table 59: BD Biosciences (Becton, Dickinson and Company) Basic Information And Sales Area

Table 60: BD Biosciences (Becton, Dickinson and Company). Products Portfolio

Table 61: Bio-Rad Laboratories, Inc. Basic Information And Sales Area

Table 62: Bio-Rad Laboratories, Inc.. Products Portfolio

Table 63: Agilent Technologies, Inc. Basic Information And Sales Area

Table 64: Agilent Technologies, Inc.. Products Portfolio

Table 65: Merck KGaA (Sigma-Aldrich) Basic Information And Sales Area

Table 66: Merck KGaA (Sigma-Aldrich). Products Portfolio

Table 67: QIAGEN N.V. Basic Information And Sales Area

Table 68: QIAGEN N.V.. Products Portfolio

Table 69: Genentech (Roche) Basic Information And Sales Area

Table 70: Genentech (Roche). Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global kras antibody Market Value (USD Million) By Region

Table 80: Global kras antibody Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global kras antibody Market Volume (K) By Region

Table 97: Global kras antibody Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

kras antibody Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abcam plc; Thermo Fisher Scientific Inc.; Cell Signaling Technology, Inc.; Santa Cruz Biotechnology, Inc.; BD Biosciences (Becton, Dickinson and Company); Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Merck KGaA (Sigma-Aldrich); QIAGEN N.V.; Genentech (Roche)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High development costs and regulatory hurdles are limiting the entry of new players in the kras antibody market, making it challenging for smaller companies to compete with established firms.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

kras antibody Segmentation Breakdown10 items

Application

Flow Cytometry

ELISA

Western Blot

Immunoprecipitation

Immunofluorescence

Others

Types

Monoclonal Antibody

Polyclonal Antibody

Regional Insights

Loading chart…

Competitive Landscape

Abcam plc: regional expansion

Thermo Fisher Scientific Inc.: innovation pipeline

Cell Signaling Technology, Inc.: premium pricing

Santa Cruz Biotechnology, Inc.: OEM tie-ups

BD Biosciences: local manufacturing

Bio-Rad Laboratories, Inc.: vertical integration

Key kras antibody Companies10 items

Abcam plc

Thermo Fisher Scientific Inc.

Cell Signaling Technology, Inc.

Santa Cruz Biotechnology, Inc.

BD Biosciences (Becton, Dickinson and Company)

Bio-Rad Laboratories, Inc.

Agilent Technologies, Inc.

Merck KGaA (Sigma-Aldrich)

QIAGEN N.V.

Genentech (Roche)

Market Ecosystem

Raw material/component suppliers — provide essential materials

Technology providers — develop and license kras antibody technologies

OEMs / manufacturers — produce kras antibodies

Distributors / channel partners — deliver products to end users

Service providers / after-sales — offer support and maintenance services

End users / buyers — purchase and utilize kras antibodies

Regulators/standards bodies — establish guidelines and approvals

Recent Industry Insights

Analyst Overview

Table of Contents